YZR Capital

Many thanks to Sifted for recognizing us as one of Europe’s most active health tech investors! 🎉 This achievement belongs to the exceptional founders who entrust us to back them and make us proud daily with their work. With 10 new deals and 8 follow-ons, we were not holding back this year. True to our mission, we doubled down on accelerating health tech disruption in Europe, especially in a market that needs direction on deploying capital. Backed by a strong base of institutional investors and family offices in our health tech-focused €100m YZR Capital Fund I, we remain committed to driving innovation in this sector. What excites us most isn’t just the number of deals we made, but the fact that with our unique team setting combining founder, investor, healthcare practitioner, and healthcare C-Level expertise, we put ourselves in a position to have a high conviction approach – resulting in us leading or co-leading 100% of the new deals we made, and therefore mobilizing further capital for the ecosystem. 🚀 Thank you to our portfolio for trusting us! Link to article in 1st comment. clare&me (Emilia) | flair (Evgenii) | Bloom (Viktoria) | Holi (Pawel S.) | Kalia Lab (Max & Dr. Constantin) | OpenHealth Technologies (Gerrit) | Univa (Richard) | Scan.com (Charlie) | apoQlar medical (Sirko) | uPacjenta.pl (Dominik) | deepeye Medical (Manuel) | IQONIC.AI (Martin & Maria-Liisa) | filu (Christian) | Deemea (Charlotte) | BIORCE (Pedro) | Esper Bionics (Dima Gazda) and several unannounced ones :) #healthtech #venturecapital

Meet us at Slush today or tomorrow! ❄️ Proud to see 5 of our portfolio companies ramping up their global presence. If you would like to meet some amazing early-stage health tech startups, reach out to BIORCE (Pedro Coelho & Clara Bernardes), Esper Bionics (Dima Gazda), Holi (Pawel), IQONIC.AI (Martin Pentenrieder) or clare&me (Emilia Theye)! Markus Feuerecker Paul Epple Till Quitzau Christina Schmidt #slush2024 #healthtech

Welcome to our portfolio, BIORCE! 👋 Biorce is a Spain-based TechBio innovator dedicated to revolutionizing the field of clinical trials through AI. We’re excited to share that together with MSM fund (Mustard Seed Maze) we co-led their €3.5m oversubscribed funding round, with participation from Outsized Ventures, PATHENA, and Plug and Play Tech Center. BIORCE builds an AI-driven platform that streamlines clinical trials by automating protocol development and feasibility assessments, with the vision to reduce costs and shorten the time required for drug development. The company is led by an experienced team with a strong background in CROs, clinicals trials management, and programming. Pedro Coelho, Co-Founder & CEO at Biorce states: “Clinical trials are crucial for drug development but remain hindered by inefficiencies, data fragmentation, and complex logistical challenges. We're transforming this landscape through our multi-modality platform and Jarvis, our proprietary AI model, making trials faster, more efficient, and accessible to all.”   Congrats to Pedro, Clara Bernardes, José Faria, Diogo Pisoeiro and their team! We are very happy to be on board! 🙏 #healthtech #venturecapital

Three days left to apply for Pitchbühel 2025! ⌛ If you're an early-stage Health Tech founder and would like to pitch your startup to the YZR team in a gondola, don't forget to apply! In the last edition we ended up investing in one of the participants, so it's an event worth joining. Here the short facts: ⏲️ Day trip on January 30th 📍 Kitzbühel (transport will be provided from and to Munich) 👤 20 Health Tech founders + YZR team 🎿 Networking, skiing, pitching, après-ski Application link in the 1st comment. #startups #healthtech

Meet us in Helsinki! ❄️ We can't wait to attend Slush next week, one of our favorite conferences! If you're there and keen to discuss anything Health Tech or learn more about YZR Capital, reach out to Markus Feuerecker, Christina Schmidt, Paul Epple, or Till Quitzau! Looking forward to seeing many of you there. 👋 #slush2024 #healthtech #venturecapital

Only three weeks left to apply for our Pitchbühel event in January! If you're a European early-stage health tech founder and are keen to pitch your company to the YZR Capital team in a gondola, don't forget to apply.⛷️🎤 Application link in first comment. #healthtech #startups

The time has finally come – the registration for Pitchbühel 2.0 opens today! 🔊   After we got incredible feedback from our founders last year and ended up investing in one of the founders who pitched us their company for the first time in the gondola (not announced yet), we decided Pitchbühel must become a yearly tradition.   So we will follow the same procedure as last year: only one week after the legendary Streif Hahnenkamm race where the world meets in Kitzbühel to celebrate the heroes of skiing, we are looking for the next heroes in health tech. We are inviting 20 digital health founders to join us for an unforgettable day trip to Kitzbühel which could be their ticket to raising their round with us.   While sitting with the YZR Capital team in the Hahnenkamm gondola, surrounded by breathtaking views of the alps, you will have the opportunity to pitch your company. Before and after pitching, there will be plenty of time to hit the slopes together, followed by joint drinks and food.   In short, the main facts: ⏱️ January 30th 📍 Kitzbühel – meeting point is Munich, we will take care of your transport ⛷️ Pitching, skiing, drinking, networking   If you’re a health tech founder and would like to participate in the event, please fill out our application form by November 15th. Link in 1st comment!   We can’t wait! 🏂 #healthtech #startups #event

Welcome to our portfolio, Univa! 👋 UK-based Univa is revolutionizing eating disorder care with a novel personalized digital platform. We’re excited to share that we have led the £1m pre-seed round, with participation from Calm/Storm. Over the past five years, hospital admissions for eating disorders have surged by 84% in the UK. The lack of personalization in treatments, combined with a shortage of skilled clinicians, results in half of those with eating disorders not responding to treatment. Despite the need for early intervention, the NHS is only able to provide care for 10% of adults with eating disorders. Richard Andrews, Co-Founder & CEO at Univa comments: “Our goal is to revolutionise care pathways, providing tools that empower clinicians and deliver meaningful results. We aim to keep people out of hospital and enable better long-term recovery while saving costs for the healthcare system. Univa’s platform will augment the overwhelmed clinical workforce by providing evidence-based tools to reach more patients and families, enabling earlier intervention, improving monitoring, and faster recovery.”   We’re happy to back two experienced healthcare founders on this mission – looking forward to our journey together Richard Andrews and Jose Santos! 💥 #healthcare #venturecapital  

We had a blast with top #HealthTech founders and investors at the *HealthTech x Google* event last week in Berlin! 🚀 The energy was incredible, and if you want to know where the future of healthcare investment is headed, this is the event to keep on your radar. 💡   We had the privilege of co-hosting this event alongside Google & Revent as well as Creandum, Lightrock, General Catalyst, Speedinvest, Amino Collective, Sofinnova Partners, and Heal Capital. Together, we brought some of the most innovative founders and cutting-edge investors in European healthcare to the table. 🩺   The event also featured roundtable discussions with deep dives into emerging trends. 💡 Key takeaways from the roundtable by our founding partner Reinhard Meier, MD MBA, on LLMs in healthcare: We discussed the primary and secondary benefits of LLMs in healthcare, as well as use cases such as medical documentation automation, patient record aggregation, clinical trial matching, virtual health assistants, symptom checkers, clinical decision support and treatment recommendations, personalised patient communications, claims automation, scheduling and workflow optimization, drug discovery and development, and last but not least, mental health support as our portfolio company clare&me.   Huge thanks to Franca Pullem and Otto Birnbaum for the great organization! 👏  Thanks to co-hosts and attendees: Javier Nunez-Vicandi Alexandre Momeni Andrea Zitna Hendrik Steenfadt, MD Hannah Looks Manuel Grossmann, Tim Schneider, Dr. Sievert Weiss, Dr. Laura Seifert, Luisa Wasilewski, Edward Kliphuis, Martin Karschkes, Beata Klein, Amelia Zins, Christopher Steinau, Nicolas Weber, Peter Schlecht & many more. #healthtech #venturecapital

Welcome to the YZR team, Till Quitzau! 👋 We are thrilled to welcome Till Quitzau as our new Investment Analyst at YZR Capital! With experience from Bain & Company and internships at redalpine, Bank of America, and PlusDental, Till will make valuable contributions to our investment team.   Till holds a Master’s in International Management from Esade and a Bachelor’s in Business Administration from the University of Mannheim. In his free time, you will most likely find him at a tennis court or football field or following his love for good music.   Till Quitzau, we are happy to have you on board! ☀ #venturecapital #healthtech